Goldman Sachs Group Inc Conmed Corp Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Conmed Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 135,915 shares of CNMD stock, worth $9.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

135,915

Previous 125,268 8.5%

Holding current value

$9.56 Million

Previous $8.68 Million 12.58%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.09 - $76.92 $682,366 - $818,967	10,647 Added 8.5%	135,915 $9.78 Million
Q2 2024 Aug 13, 2024	SELL	$61.9 - $80.36 $9.12 Million - $11.8 Million	-147,315 Reduced 54.04%	125,268 $8.68 Million
Q1 2024 May 15, 2024	SELL	$75.36 - $112.51 $7.43 Million - $11.1 Million	-98,558 Reduced 26.56%	272,583 $21.8 Million
Q4 2023 Feb 13, 2024	BUY	$91.3 - $115.05 $1.31 Million - $1.65 Million	14,332 Added 4.02%	371,141 $40.6 Million
Q3 2023 May 14, 2024	SELL	$97.55 - $135.91 $1.4 Million - $1.95 Million	-14,332 Reduced 3.86%	356,809 $36 Million
Q3 2023 Nov 14, 2023	SELL	$97.55 - $135.91 $792,203 - $1.1 Million	-8,121 Reduced 2.23%	356,809 $36 Million
Q2 2023 May 14, 2024	SELL	$102.55 - $136.38 $6.45 Million - $8.58 Million	-62,906 Reduced 14.7%	364,930 $49.6 Million
Q2 2023 Aug 14, 2023	SELL	$102.55 - $136.38 $6.45 Million - $8.58 Million	-62,906 Reduced 14.7%	364,930 $49.6 Million
Q1 2023 May 14, 2024	BUY	$89.75 - $107.27 $4.71 Million - $5.63 Million	52,489 Added 13.98%	427,836 $44.4 Million
Q1 2023 May 11, 2023	BUY	$89.75 - $107.27 $4.71 Million - $5.63 Million	52,489 Added 13.98%	427,836 $44.4 Million
Q4 2022 May 14, 2024	SELL	$72.84 - $94.04 $9.47 Million - $12.2 Million	-129,993 Reduced 25.72%	375,347 $33.3 Million
Q4 2022 Feb 13, 2023	SELL	$72.84 - $94.04 $9.47 Million - $12.2 Million	-129,993 Reduced 25.72%	375,347 $33.3 Million
Q3 2022 May 14, 2024	BUY	$77.78 - $103.92 $888,325 - $1.19 Million	11,421 Added 2.31%	505,340 $40.5 Million
Q3 2022 Nov 10, 2022	BUY	$77.78 - $103.92 $888,325 - $1.19 Million	11,421 Added 2.31%	505,340 $40.5 Million
Q2 2022 May 14, 2024	BUY	$88.23 - $154.18 $10.8 Million - $18.9 Million	122,778 Added 33.08%	493,919 $47.3 Million
Q2 2022 Aug 15, 2022	SELL	$88.23 - $154.18 $7.27 Million - $12.7 Million	-82,447 Reduced 14.3%	493,919 $47.3 Million
Q1 2022 May 16, 2022	SELL	$121.88 - $150.0 $4.15 Million - $5.11 Million	-34,055 Reduced 5.58%	576,366 $85.6 Million
Q4 2021 Feb 14, 2022	BUY	$129.86 - $157.03 $9.86 Million - $11.9 Million	75,933 Added 14.21%	610,421 $86.5 Million
Q3 2021 Nov 10, 2021	BUY	$122.87 - $139.12 $65.7 Million - $74.4 Million	534,488 New	534,488 $69.9 Million

Others Institutions Holding CNMD

# of Institutions

307

Shares Held

33.1M

Call Options Held

123K

Put Options Held

24.2K

View Full List

About CONMED Corp

Ticker CNMD
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 30,482,400
Market Cap $2.14B
Description
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...

More about CNMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Conmed Corp Transaction History